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============

Toxoplasmosis occurs in advanced stages of human immunodeficiency virus (HIV) infection and is the most common opportunistic infection of the central nervous system in patients with the acquired immunodeficiency syndrome (AIDS), especially in those patients with a CD4+ count \<200 cells/mm^3^ \[[@B1],[@B2]\]. The most common clinical presentation of cerebral toxoplasmosis in patients with HIV infection is headache, focal neurological deficits and seizures. Prompt diagnosis and appropriate therapy results in rapid clinical and radiological improvement \[[@B1]\]. Here, we present two cases with stroke-like presentation of cerebral toxoplasmosis from our centre.

Case 1 {#sec1_2}
======

A 30-year-old right-handed Nigerian woman was admitted to the University of Calabar Teaching Hospital, Nigeria, with a 1-week history of inability to move the left upper and lower limbs of acute onset. There was a history of headache, but no seizures, vomiting or loss of consciousness. She was not known to be hypertensive or diabetic, and she does not drink alcohol nor does she smoke. The patient was diagnosed to be HIV positive about 2 years prior to this admission and commenced on antiretroviral drugs (ARV) but defaulted on therapy for about 1 year prior to the current presentation. Her latest CD4+ count was not known.

On neurologic examination, she showed left upper motor neuron facial nerve palsy and increased tone and brisk reflexes in both left upper and lower limbs. Power was grade 0/5 and grade 1/5 in the left upper and lower limbs, respectively, on the Medical Research Council scale, with a positive Babinski sign on the left. A brain CT scan revealed a rounded ring-enhancing hypodense lesion in the parafalcine region of the right parietal cortex (fig. [1a, b](#F1){ref-type="fig"}). A complete blood count revealed low haemoglobin (8 g/dl), ESR 80 mm in the first hour, and CD4+ count 18 cells/mm^3^. Toxoplasma IgM was 0.14 IU/l and toxoplasma IgG was 202.0 IU/l, both markedly raised.

A diagnosis of stroke-like syndrome due to cerebral toxoplasmosis in the background of HIV infection was made and the patient was commenced on pyrimethamine (200 mg at start, then 50 mg daily), clindamycin (600 mg every 6 h), folic acid (10 mg daily), septrin (960 mg b.i.d.), amoxicillin/clavulanic acid (625 mg t.d.s.), and haematinics. Two weeks after treatment, the patient resumed ARV therapy with Truvada and Lopinavir/Ritonavir. Power gradually improved to 4/5 in both limbs, and she started ambulating and was discharged to follow-up as an outpatient.

Case 2 {#sec1_3}
======

A 35-year-old female was referred to the University of Calabar Teaching Hospital, Nigeria, with a 2-day history of left-sided weakness affecting her leg and arm and focal seizures involving her left upper limb. She had headaches but no vomiting or alteration of consciousness. She had a history of HIV infection, diagnosed 4 years prior to the current presentation and treated with ARV drugs. Her last CD4+ count (6 months before) was 28 cells/mm^3^.

On neurologic examination, there was left hemiparesis (grade 3:5 on the Medical Research Council scale for both left upper and lower limbs) with increased tone and brisk reflexes and upgoing plantar reflexes (Babinski sign). An urgent brain CT showed a rounded marginally enhancing hyperdense lesion with perilesional oedema in the right thalamus (fig. [1c, d](#F1){ref-type="fig"}). There was obliteration of the posterior horn of the ipsilateral lateral ventricle by the aforementioned mass. A similar but ill-defined lesion with more extensive perilesional oedema was also noted within the ipsilateral parietal lobe.

Blood tests showed haemoglobin 10 g/dl, ESR 106 mm in the first hour, CD4+ count 24 cells/mm^3^ and toxoplasma IgG antibody 300 IU/l. Based on these findings, a diagnosis of cerebral toxoplasmosis presenting with a stroke-like syndrome, on the background of HIV treatment failure, was made. The patient was commenced on appropriate treatment and her muscle power gradually improved. She then started ambulating, while focal seizures ceased. The patient was discharged home to continue follow-up at the medical outpatient department.
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